U.S. flag

An official website of the United States government

NM_001083116.3(PRF1):c.797T>C (p.Ile266Thr) AND Familial hemophagocytic lymphohistiocytosis 2

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 1, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001066139.7

Allele description [Variation Report for NM_001083116.3(PRF1):c.797T>C (p.Ile266Thr)]

NM_001083116.3(PRF1):c.797T>C (p.Ile266Thr)

Gene:
PRF1:perforin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q22.1
Genomic location:
Preferred name:
NM_001083116.3(PRF1):c.797T>C (p.Ile266Thr)
HGVS:
  • NC_000010.11:g.70598924A>G
  • NG_009615.1:g.8852T>C
  • NM_001083116.3:c.797T>CMANE SELECT
  • NM_005041.6:c.797T>C
  • NP_001076585.1:p.Ile266Thr
  • NP_005032.2:p.Ile266Thr
  • LRG_94t1:c.797T>C
  • LRG_94:g.8852T>C
  • NC_000010.10:g.72358680A>G
  • NM_001083116.1:c.797T>C
Protein change:
I266T
Links:
dbSNP: rs763667216
NCBI 1000 Genomes Browser:
rs763667216
Molecular consequence:
  • NM_001083116.3:c.797T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_005041.6:c.797T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Familial hemophagocytic lymphohistiocytosis 2 (FHL2)
Identifiers:
MONDO: MONDO:0011337; MedGen: C1863727; Orphanet: 540; OMIM: 603553

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001231138Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Sep 1, 2021)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Spectrum of Atypical Clinical Presentations in Patients with Biallelic PRF1 Missense Mutations.

Tesi B, Chiang SC, El-Ghoneimy D, Hussein AA, Langenskiöld C, Wali R, Fadoo Z, Silva JP, Lecumberri R, Unal S, Nordenskjöld M, Bryceson YT, Henter JI, Meeths M.

Pediatr Blood Cancer. 2015 Dec;62(12):2094-100. doi: 10.1002/pbc.25646. Epub 2015 Jul 16.

PubMed [citation]
PMID:
26184781

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001231138.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This sequence change replaces isoleucine with threonine at codon 266 of the PRF1 protein (p.Ile266Thr). The isoleucine residue is moderately conserved and there is a moderate physicochemical difference between isoleucine and threonine. This variant is present in population databases (rs763667216, ExAC no frequency). This missense change has been observed in individual(s) with hemophagocytic lymphohistiocytosis (PMID: 26184781). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024